Notably, approximately 74% of Tregs isolated from the peripheral blood of GBM patients express CCR4, compared with only about 43% in healthy individuals, suggesting that GBM may induce or upregulate CCR4 expression on Tregs through soluble factors in the tumor milieu [89]. The gene discussed is CCR4; the disease is neoplasm.